First, hyperhomocysteinemia detected only in the fasting state (approximately 23% of patients), which might mainly result from an inhibition of the homocysteine remethylation pathway (folate, cobalamin, or functional methionine synthase deficiencies or thermolabile MTHFR mutation), and which increases the cardiovascular risk 1.6-fold
Meeting safety and health standards is crucial, and ensuring compliance requires significant investment in quality control and testing
Third, altered microbial metabolism may shift the balance away from SCFA-rich, tolerance-supporting conditions toward lipopolysaccharide-rich, low-grade inflammatory states
1-page printable handout Prepared by Danielle Alcala-Glazier Patient Education Series START Peptides 101 Educational Cheat Sheet What peptides are, how they work, regulatory tiers & smart questions